Although the correlation of poor prognosis with expression has largely implicated a pro-tumor role of B7-H3 expression across many tumor types, there is emerging evidence that B7-H3 expression is also linked to therapeutic resistance to chemotherapy, and increased metastasis6,45. The gene discussed is CD276; the disease is neoplasm.